title: Formularies, costs, and quality of care: Formulary restrictions are not the answer, especially for epilepsy.
abstract: The goal of treating an individual with epilepsy is to have no seizures and no side effects. Limiting availability of medications appears to be a simple way of controlling costs of patient care. This approach potentially jeopardizes both efficacy and safety. We argue, in this edition ofCurrent Controversies, that limiting costs by restricting formularies is detrimental to the patients from an efficacy, safety, and cost perspective.
authors: Departments of Neurology (DML, KWD) and Pharmacy Practice & Science (DML), Colleges of Medicine and Pharmacy, The University of Arizona, Tucson.
authors: David M
authors: DM
authors: Labiner
authors: Kendra W
authors: KW
authors: Drake
references: N Engl J Med. 2000 Feb 3;342(5):314-9
references: 10660394
references: Neurology. 2004 Apr 27;62(8):1261-73
references: 15111660
references: Epilepsia. 2006 Jul;47(7):1094-120
references: 16886973
references: Neurology. 2010 May 18;74(20):1566-74
references: 20393142